Form D · Pharmaceuticals
Innate Pharma, SA
Marseille, I0 · CIK 0001598599
Offering snapshot reported Jan 31, 2014 · SEC filing
- Reported sold
- $27.4M Offering amount: $27.4M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 19, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 31, 2014 | Initial | $27,417,392 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.64M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-211065
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Leerink Swann LLC | 39011 |
Source: Form D, filed Jan 31, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Herve Brailly | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
117 Avenue De Luminy
Marseille, I0, 13009
Marseille, I0, 13009